Correction

Fischbach M, Wühl E, Reigner SCM, Morgan Z, Schaefer F: Efficacy and long-term safety of C.E.R.A. maintenance in pediatric hemodialysis patients with anemia of CKD. Clin J Am Soc Nephrol 13: 81–90, 2018.

Because of author error, a correction has been issued for the above referenced article. The authors and editors have determined that the disclosures provided by Michel Fischbach and Elke Wühl at the time of initial publication were incomplete and not aligned with the disclosure policy for the journal. The disclosures as provided in the original article are included below, as well as the corrected disclosures for the authors.

Table 1.

Corrected disclosures (corrections are bolded)

Author	Original Disclosures	Corrected Disclosures
Michel Fischbach	M.F. discloses consultancy and honoraria for Fresenius Medical Care.	M.F. reports personal fees from Fresenius Medical Care, and other funding from Roche, outside the submitted work.
Sylvie C. Meyer Reigner	S.C.M.R. and Z.M. are employees of F. Hoffmann-La Roche Ltd.	S.C.M.R. and Z.M. are employees of F. Hoffmann-La Roche Ltd.
Zoe Morgan	S.C.M.R. and Z.M. are employees of F. Hoffmann-La Roche Ltd.	S.C.M.R. and Z.M. are employees of F. Hoffmann-La Roche Ltd.
Franz Schaefer	F.S. discloses consultancy for F. Hoffmann-la Roche Ltd., Bayer, Amgen, AbbVie, Alexion, and Otsuka; research funding from Fresenius Medical Care; honoraria from Alexion; and scientific advisory board activities for Alexion and Otsuka.	F.S. discloses consultancy for F. Hoffmann-la Roche Ltd., Bayer, Amgen, AbbVie, Alexion, and Otsuka; research funding from Fresenius Medical Care; honoraria from Alexion; and scientific advisory board activities for Alexion and Otsuka.
Elke Wühl	E.W. has no conflicts to disclose.	E.W. reports patient fees from Roche, during the conduct of the study.